Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001811764-22-000066
Filing Date
2022-08-12
Accepted
2022-08-12 08:23:02
Documents
8
Effectiveness Date
2022-08-12

Document Format Files

Seq Description Document Type Size
1 S-8 pnt_forms-8xevergreenincre.htm S-8 68355
2 EX-FILING FEES exhibit1071-formsx8filingf.htm EX-FILING FEES 17991
3 EX-5.1 exhibit51-opinionofbassber.htm EX-5.1 10462
4 EX-23.2 exhibit232-consentofarmani.htm EX-23.2 4801
5 bbsa.jpg GRAPHIC 3438
6 image_0a.jpg GRAPHIC 269
7 image_1a.jpg GRAPHIC 5938
8 imagea.jpg GRAPHIC 4812
  Complete submission text file 0001811764-22-000066.txt   122037
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

EIN.: 850800493 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266812 | Film No.: 221157923
SIC: 2834 Pharmaceutical Preparations